Clinical Trial Update: ECT vs. Esketamine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing electroconvulsive therapy (ECT) versus esketamine for treatment resistant depression and major depressive disorder has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• ECT
• Esketamine (esketamine)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 3 | Status: WITHDRAWN